Laura Piccinini - 21 Jul 2021 Form 3 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
SVP International
Signature
/s/ Richard C. Rosenzweig, Attorney-in-Fact
Issuer symbol
ANGO
Transactions as of
21 Jul 2021
Net transactions value
$0
Form type
3
Filing time
27 Jul 2021, 18:27:51 UTC
Next filing
22 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ANGO Common Stock 10,000 21 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ANGO Non-Qualified Stock Option (right to buy) 21 Jul 2021 Common Stock 50,000 $26.49 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock of AngioDynamics, Inc. ("Common Stock") represent 10,000 shares of Common Stock underlying restricted stock units which vest in four equal annual installments beginning on June 1, 2022, such that 25% of the restricted stock units will vest on each of June 1, 2022, 2023, 2024 and 2025.
F2 These stock options vest in four equal annual installments beginning on June 1, 2022, such that 25% of the options will vest on each of June 1, 2022, 2023, 2024 and 2025.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney